LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Dasatinib | 1.11 | uM | LJP6 | 72 | hr | 658 | 574 | 3846 | 0.1494 | -0.0262 |
Hs 578T | Dovitinib | 1.11 | uM | LJP5 | 72 | hr | 658 | 1029 | 3846 | 0.2675 | 0.1163 |
Hs 578T | Enzastaurin | 1.11 | uM | LJP5 | 72 | hr | 658 | 4153 | 3846 | 1.0799 | 1.0964 |
Hs 578T | Erlotinib | 1.11 | uM | LJP5 | 72 | hr | 658 | 3767 | 3846 | 0.9795 | 0.9753 |
Hs 578T | Foretinib | 1.11 | uM | LJP5 | 72 | hr | 658 | 1208 | 3846 | 0.3143 | 0.1727 |
Hs 578T | R406 | 1.11 | uM | LJP6 | 72 | hr | 658 | 2773 | 3846 | 0.7210 | 0.6634 |
Hs 578T | Pictilisib | 1.11 | uM | LJP6 | 72 | hr | 658 | 2100 | 3846 | 0.5461 | 0.4524 |
Hs 578T | Gefitinib | 1.11 | uM | LJP6 | 72 | hr | 658 | 3741 | 3846 | 0.9728 | 0.9671 |
Hs 578T | Geldanamycin | 1.11 | uM | LJP5 | 72 | hr | 658 | 798 | 3846 | 0.2075 | 0.0439 |
Hs 578T | Geldanamycin | 1.11 | uM | LJP6 | 72 | hr | 658 | 726 | 3846 | 0.1888 | 0.0213 |
Hs 578T | GSK1059615 | 1.11 | uM | LJP5 | 72 | hr | 658 | 1523 | 3846 | 0.3961 | 0.2714 |
Hs 578T | GSK1059615 | 1.11 | uM | LJP6 | 72 | hr | 658 | 1663 | 3846 | 0.4326 | 0.3154 |
Hs 578T | GSK1904529A | 1.11 | uM | LJP6 | 72 | hr | 658 | 3566 | 3846 | 0.9272 | 0.9121 |
Hs 578T | Omipalisib | 1.11 | uM | LJP6 | 72 | hr | 658 | 516 | 3846 | 0.1343 | -0.0444 |
Hs 578T | GSK 690693 | 1.11 | uM | LJP5 | 72 | hr | 658 | 3159 | 3846 | 0.8214 | 0.7845 |
Hs 578T | GW843682X | 1.11 | uM | LJP6 | 72 | hr | 658 | 517 | 3846 | 0.1344 | -0.0443 |
Hs 578T | HG-5-113-01 | 1.11 | uM | LJP5 | 72 | hr | 658 | 1157 | 3846 | 0.3010 | 0.1567 |
Hs 578T | HG-5-88-01 | 1.11 | uM | LJP6 | 72 | hr | 658 | 3128 | 3846 | 0.8134 | 0.7748 |
Hs 578T | Imatinib | 1.11 | uM | LJP6 | 72 | hr | 658 | 3672 | 3846 | 0.9547 | 0.9454 |
Hs 578T | JNK-9L | 1.11 | uM | LJP6 | 72 | hr | 658 | 1316 | 3846 | 0.3422 | 0.2063 |
Hs 578T | JW-7-24-1 | 1.11 | uM | LJP6 | 72 | hr | 658 | 2001 | 3846 | 0.5203 | 0.4212 |
Hs 578T | Lapatinib | 1.11 | uM | LJP6 | 72 | hr | 658 | 3746 | 3846 | 0.9740 | 0.9686 |
Hs 578T | LDN-193189 | 1.11 | uM | LJP5 | 72 | hr | 658 | 2927 | 3846 | 0.7612 | 0.7119 |
Hs 578T | Linifanib | 1.11 | uM | LJP6 | 72 | hr | 658 | 3686 | 3846 | 0.9585 | 0.9499 |
Hs 578T | Linsitinib | 1.11 | uM | LJP5 | 72 | hr | 658 | 3586 | 3846 | 0.9324 | 0.9184 |